深圳高速公路股份(00548.HK):雲杉資本增持公司H股2538萬股
格隆匯7月25日丨深圳高速公路股份(00548.HK)發佈公吿,公司於2025年7月24日收到公司持股5%以上股東江蘇雲杉資本管理有限公司(“雲杉資本”)發來的《關於對深高速股票增持情況的吿知函》,吿知雲杉資本於2025年6月4日至2025年7月24日期間通過滬港通以集中競價方式增持公司H股股票25,378,000股。
截至2025年7月24日,雲杉資本直接持有本公司股票279,164,461股,佔公司總股本的11.00%,其中:A股股票242,976,461股,H股股票36,188,000股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.